TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biomedica Norden AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 4,335 | 4,457 | 4,149 |
Financial expenses | 111 | 144 | 182 |
Earnings before taxes | -57 | -17 | -18 |
EBITDA | 527 | 615 | 683 |
Total assets | 2,606 | 3,185 | 3,690 |
Current assets | 758 | 801 | 603 |
Current liabilities | 714 | 1,264 | 1,735 |
Equity capital | 370 | 440 | 490 |
- share capital | 95 | 98 | 105 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 14.2% | 13.8% | 13.3% |
Turnover per employee | 2,168 | 2,228 | 2,074 |
Profit as a percentage of turnover | -1.3% | -0.4% | -0.4% |
Return on assets (ROA) | 2.1% | 4.0% | 4.4% |
Current ratio | 106.2% | 63.4% | 34.8% |
Return on equity (ROE) | -15.4% | -3.9% | -3.7% |
Change turnover | 12 | 595 | -76 |
Change turnover % | 0% | 15% | -2% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.